Deconstructing the Lectin Pathway in the Pathogenesis of Experimental Inflammatory Arthritis: Essential Role of the Lectin Ficolin B and Mannose-Binding Protein-Associated Serine Protease 2.
Deconstructing the Lectin Pathway in the Pathogenesis of Experimental Inflammatory Arthritis: Essential Role of the Lectin Ficolin B and Mannose-Binding Protein-Associated Serine Protease 2.
复制标题
解构实验性炎症性关节炎发病机理中的凝集素途径:凝集素纤维蛋白B和甘露糖结合蛋白相关的丝氨酸蛋白酶2的重要作用。
DOI:
10.4049/jimmunol.1700119
复制
发表时间:
2017-09-01
期刊:
影响因子:
--
通讯作者:
Holers VM
中科院分区:
文献类型:
--
作者:
Banda NK;Acharya S;Scheinman RI;Mehta G;Takahashi M;Endo Y;Zhou W;Farrar CA;Sacks SH;Fujita T;Sekine H;Holers VM
Complement plays an important role in the pathogenesis of rheumatoid arthritis (RA). While the alternative pathway (AP) is known to play a key pathogenic role in models of RA, the importance of the lectin pathway (LP) pattern recognition molecules such as ficolin A (FCN A), ficolin B (FCN B) and collectin-11 (CL-11) as well as the activating enzyme MBL (mannose binding lectin)-associated serine protease-2 (MASP-2) are less well understood. We show here that FCN A−/− and CL-11−/− mice are fully susceptible to collagen antibody-induced arthritis (CAIA). In contrast, FCN B−/− and MASP-2−/−/sMAp−/− mice are substantially protected, with clinical disease activity decreased significantly (p < 0.05) by 47% and 70%, respectively. Histopathology scores, C3, fD, FCN B deposition and infiltration of synovial macrophages and neutrophils were similarly decreased in FCN B−/− and MASP-2−/−/sMAp−/− mice. Our data support that FCN B plays an important role in the development of CAIA, likely through ligand recognition in the joint and MASP activation, and that MASP-2 also contributes to the development of CAIA, likely in a C4-independent manner. Decreased AP activity in the sera from FCN B−/− and MASP-2−/−/sMAp−/− mice with arthritis on adherent anti-collagen antibodies also support the hypothesis that pathogenic antibodies as well as additional inflammation-related ligands are recognized by the LP and operate in vivo to activate complement. Finally, we also speculate that the residual disease seen in our studies is driven by the AP and/or the C2/C4 bypass pathway via the direct cleavage of C3 through a LP-dependent mechanism.
登录
查看更多内容
DOI:
10.4049/jimmunol.1102310
发表时间:
2012-02-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Banda NK;Hyatt S;Antonioli AH;White JT;Glogowska M;Takahashi K;Merkel TJ;Stahl GL;Mueller-Ortiz S;Wetsel R;Arend WP;Holers VM
通讯作者:
Holers VM
DOI:
10.4049/jimmunol.0901826
发表时间:
2009-11-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Banda NK;Levitt B;Glogowska MJ;Thurman JM;Takahashi K;Stahl GL;Tomlinson S;Arend WP;Holers VM
通讯作者:
Holers VM
影响因子:
3.6
作者:
Banda NK;Takahashi M;Takahashi K;Stahl GL;Hyatt S;Glogowska M;Wiles TA;Endo Y;Fujita T;Holers VM;Arend WP
通讯作者:
Arend WP
影响因子:
4.6
作者:
Banda, N. K.;Levitt, B.;Arend, W. P.
通讯作者:
Arend, W. P.
影响因子:
4.4
作者:
Banda, Nirmal K.;Takahashi, Kazue;Arend, William P.
通讯作者:
Arend, William P.